EANS-Adhoc: LifeWatch Services, Inc. hosts U.S. Congressman Chaka Fattah at its newly expanded Philadelphia Call Center for a Ribbon Cutting Ceremony and Town Hall Meeting on Healthcare Reform

ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.

09.07.2009

Philadelphia, PA - LifeWatch Services, Inc. the leading provider
of wireless telemedicine services in the U.S. and the major subsidiary of Swiss-based LifeWatch AG (SIX Swiss Exchange: LIFE), hosted the Honorable US Congressman Chaka Fattah at its Philadelphia Monitoring Center to celebrate the recent expansion of the center. Congressman Fattah toured the facility, met with the staff, and discussed how telemedicine technology will become a major component in healthcare platforms in the United States.

"Technology plays a vital role in the delivery of medicine and unfortunately healthcare has been one of the last major industries to efficiently incorporate proven technology efficiently that ultimately reduces cost and improves patient outcomes," said Congressman Fattah.

The visit was coordinated by John Mize, Director of the LifeWatch Federal Business Division, as part of an overall strategy to increase awareness in Washington of how telemedicine can transform healthcare delivery toward a virtual healthcare delivery system that focuses on new ways of managing chronic diseases, controlling costs, and improving patient outcomes. The LifeWatch Federal Business Division offers its services to U.S. government agencies, and is the only IDTF (Independent Diagnostic Test Facility) company in the wireless cardiac industry with the GSA Schedule (General Service Administration) Contract that facilitates a simplified procurement of ACT wireless monitoring services by a wide variety of U.S. government agencies. As reported in the Q4 2008 Letter to Shareholders, the revenues from LifeWatch's Federal Division grew from USD 460,000 in 2007 to USD 1.5 million in 2008.

"LifeWatch is committed to increasing awareness of telemedicine's benefits with our policymakers in Washington. It was a privilege to host Congressman Fattah at our facility and allow him to see firsthand how technology will improve the delivery of healthcare," Mize said following the visit.

The LifeWatch monitoring center in Philadelphia has grown from 60 healthcare professionals in 2008 to more than 100 today, with a goal to more than double its headcount in 2010, based on growing demand for its services.

According to Brent Atwood, Chief Operations Officer at LifeWatch, "We are ideally suited to support the transformation of healthcare in the United States with our ability to create a virtual healthcare platform that provides efficient remote management of health data, and triaged patient care from our remote monitoring center that will improve the quality and consistency of care provided to patients."

In May LifeWatch hosted U.S. Senator Dick Durbin the Majority Whip and Senior Senator from Illinois at the Rosemont facility to discuss expansion efforts and the role the company plays in President Obama's plan for healthcare reform.

About LifeWatch AG

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless cardiac monitoring services. LifeWatch services treat high-risk and chronically ill patients, health conscious consumers and wellness programs. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and LifeWatch Technologies Inc., a US-based manufacturer of telecardiology products. www.lifewatch.com

Sign-up for customized E-mail alerts and documentation requests is available at
http://production.investis.com/lifewatch/alert-service/

end of ad-hoc-announcement ================================================================================ This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

end of announcement euro adhoc

emitter: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, Hauptsegment: SIX Swiss Exchange, free trade: Berlin language: English

Rückfragen & Kontakt:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@cardguard.com

Sensus Investor and Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB0026